IDR 2430.0
(-1.62%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 1257.95 Billion IDR | 72.64% |
2022 | 728.65 Billion IDR | -34.02% |
2021 | 1104.34 Billion IDR | 2.67% |
2020 | 1075.64 Billion IDR | 34.95% |
2019 | 797.07 Billion IDR | 13.45% |
2018 | 702.57 Billion IDR | 10.79% |
2017 | 634.16 Billion IDR | -8.34% |
2016 | 691.88 Billion IDR | 0.01% |
2015 | 691.79 Billion IDR | 2.0% |
2014 | 678.25 Billion IDR | -10.47% |
2013 | 757.54 Billion IDR | 2.07% |
2012 | 742.2 Billion IDR | 11.98% |
2011 | 662.81 Billion IDR | 12.15% |
2010 | 590.99 Billion IDR | 232.64% |
2009 | -445.55 Billion IDR | -222.62% |
2008 | 363.37 Billion IDR | 13.35% |
2007 | 320.56 Billion IDR | 2.08% |
2006 | 314.04 Billion IDR | -11.16% |
2005 | 353.48 Billion IDR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 452.22 Billion IDR | 23.33% |
2024 Q3 | 513.73 Billion IDR | -29.87% |
2024 Q2 | 500.66 Billion IDR | 10.71% |
2023 Q2 | 197.99 Billion IDR | -5.37% |
2023 Q1 | 209.22 Billion IDR | 4479.34% |
2023 FY | 1257.95 Billion IDR | 72.64% |
2023 Q4 | 366.68 Billion IDR | -9.76% |
2023 Q3 | 406.37 Billion IDR | 105.24% |
2022 Q1 | 366.66 Billion IDR | 9.5% |
2022 FY | 728.65 Billion IDR | -34.02% |
2022 Q2 | 152.41 Billion IDR | -58.43% |
2022 Q4 | 4.56 Billion IDR | -97.81% |
2022 Q3 | 208.91 Billion IDR | 37.07% |
2021 Q2 | 172.47 Billion IDR | -55.59% |
2021 FY | 1104.34 Billion IDR | 2.67% |
2021 Q4 | 334.84 Billion IDR | 60.44% |
2021 Q3 | 208.7 Billion IDR | 21.0% |
2021 Q1 | 388.32 Billion IDR | 0.58% |
2020 Q1 | 378.72 Billion IDR | 42.43% |
2020 FY | 1075.64 Billion IDR | 34.95% |
2020 Q2 | 126.96 Billion IDR | -66.48% |
2020 Q3 | 183.86 Billion IDR | 44.82% |
2020 Q4 | 386.09 Billion IDR | 109.99% |
2019 Q4 | 265.9 Billion IDR | 116.48% |
2019 Q2 | 149.97 Billion IDR | -41.95% |
2019 Q1 | 258.36 Billion IDR | 44.17% |
2019 FY | 797.07 Billion IDR | 13.45% |
2019 Q3 | 122.83 Billion IDR | -18.1% |
2018 FY | 702.57 Billion IDR | 10.79% |
2018 Q4 | 179.21 Billion IDR | 52.26% |
2018 Q3 | 117.69 Billion IDR | -25.02% |
2018 Q2 | 156.96 Billion IDR | -36.88% |
2018 Q1 | 248.69 Billion IDR | 45.89% |
2017 FY | 634.16 Billion IDR | -8.34% |
2017 Q1 | 244.8 Billion IDR | 49.46% |
2017 Q2 | 146.49 Billion IDR | -40.16% |
2017 Q3 | 72.39 Billion IDR | -50.58% |
2017 Q4 | 170.47 Billion IDR | 135.48% |
2016 Q1 | 231.7 Billion IDR | 176.19% |
2016 FY | 691.88 Billion IDR | 0.01% |
2016 Q4 | 163.79 Billion IDR | 36.5% |
2016 Q3 | 119.99 Billion IDR | -31.97% |
2016 Q2 | 176.38 Billion IDR | -23.88% |
2015 Q3 | 183.24 Billion IDR | 3.51% |
2015 Q4 | 83.89 Billion IDR | -54.22% |
2015 FY | 691.79 Billion IDR | 2.0% |
2015 Q1 | 247.61 Billion IDR | 222.76% |
2015 Q2 | 177.03 Billion IDR | -28.5% |
2014 Q2 | 194.43 Billion IDR | -28.59% |
2014 FY | 678.25 Billion IDR | -10.47% |
2014 Q4 | 76.71 Billion IDR | -43.1% |
2014 Q3 | 134.82 Billion IDR | -30.66% |
2014 Q1 | 272.27 Billion IDR | 150.14% |
2013 Q1 | 255.66 Billion IDR | 115.31% |
2013 FY | 757.54 Billion IDR | 2.07% |
2013 Q4 | 108.85 Billion IDR | -31.71% |
2013 Q3 | 159.39 Billion IDR | -31.77% |
2013 Q2 | 233.62 Billion IDR | -8.62% |
2012 Q3 | 151.52 Billion IDR | -34.51% |
2012 Q4 | 118.74 Billion IDR | -21.64% |
2012 FY | 742.2 Billion IDR | 11.98% |
2012 Q1 | 240.55 Billion IDR | 162.7% |
2012 Q2 | 231.38 Billion IDR | -3.81% |
2011 FY | 662.81 Billion IDR | 12.15% |
2011 Q3 | 161.3 Billion IDR | -20.49% |
2011 Q4 | 91.56 Billion IDR | -43.23% |
2011 Q2 | 202.87 Billion IDR | -2.02% |
2011 Q1 | 207.06 Billion IDR | 0.0% |
2010 FY | 590.99 Billion IDR | 232.64% |
2009 FY | -445.55 Billion IDR | -222.62% |
2008 FY | 363.37 Billion IDR | 13.35% |
2007 FY | 320.56 Billion IDR | 2.08% |
2006 FY | 314.04 Billion IDR | -11.16% |
2005 FY | 353.48 Billion IDR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
PT Darya-Varia Laboratoria Tbk | 190.05 Billion IDR | -561.907% |
PT Merck Tbk | 199.72 Billion IDR | -529.829% |
PT Phapros, Tbk | 71.32 Billion IDR | -1663.8% |
PT Pyridam Farma Tbk | 1.87 Billion IDR | -66830.629% |
PT Industri Jamu dan Farmasi Sido Muncul Tbk | 1190.87 Billion IDR | -5.633% |